Maternal Deaths Due to Cardiovascular Disease Doubled in US Since 1999
Drug Topics
APRIL 1, 2025
Black women and those living in Southern states had the highest rates of maternal mortality.
Tue.Apr 01, 2025
492 
HHS starts layoffs of thousands of workers across its agencies
STAT
APRIL 1, 2025
Layoff notices began arriving early Tuesday for thousands of employees of the sprawling Department of Health and Human Services and its subsidiary agencies, with as many 10,000 workers potentially expected to be hit by the cuts. “I regret to inform you that you have been affected by a reduction in force (RIF) action,” an email to affected employees said.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
COVID-19 Five Years Later
Drug Topics
APRIL 1, 2025
Community pharmacies have a clear role in public health, as they manage ongoing services and take on a more significant role as immunizers.
Opinion: Former CDC Director Tom Frieden: Cuts to the agency will cost American lives and dollars
STAT
APRIL 1, 2025
The CDC cuts announced Tuesday threaten America’s health, safety, and economy. Despite claims of efficiency, these cuts target proven programs that prevent disease and save lives — and as a result, Americans will be sicker and face increased health care costs. The government’s goal should not be to hit an arbitrary number of jobs eliminated, but to focus on the number of illnesses and premature deaths prevented.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Mailing Campaign Feasible, Effective in Improving Pneumococcal Vaccine Rates
Drug Topics
APRIL 1, 2025
Researchers explored the efficacy of a targeted mailing campaign for improving pneumococcal vaccination coverage among adults 65 and over.
STAT+: FDA Commissioner Marty Makary gets off to a bruising start as agency is wracked by layoffs
STAT
APRIL 1, 2025
WASHINGTON — Marty Makary’s first official day as commissioner of the Food and Drug Administration began with employees in tears, learning from security guards that they were losing their jobs. The news release announcing the start of his tenure points readers to a press office that, after large-scale layoffs, basically no longer exists.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
More Uncertainty and Less Advice from FDA Means Companies will Need to Even More Carefully Chart their own Course to Achieve their Goals
The FDA Law Blog
APRIL 1, 2025
By Dr. Naomi Lowy, Principal Drug Regulatory Expert Trade and national press have reported that recent changes in FDA staffing levels have already led to slower responses to calls and emails. According to reports, which were published before the most recent reports of HHS staff level reductions and tumultuous changes in leadership, FDA staff were missing minor deadlines.
Dispensing Leadership: Philosophies for Teamwork
Drug Topics
APRIL 1, 2025
In this episode of the podcast, Shawn and Jesse outline 3 key principles about teamwork that can drive success in the pharmacy.
With government health info in limbo, drugmakers lose credible sources
PharmaVoice
APRIL 1, 2025
The lack of clear communication from the government could spark wide-ranging issues in pharma — from sowing confusion about clinical trial design to further eroding public trust.
FDA Approves Freeze-Dried Formulation of Smallpox, Mpox Vaccine
Drug Topics
APRIL 1, 2025
The approval expands the flexibility of storing the vaccine to protect against smallpox events or mpox outbreaks.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Former Pfizer CSO Mikael Dolsten on writing his next chapter, embracing AI and asking the ‘big questions’
PharmaVoice
APRIL 1, 2025
Dr. Mikael Dolsten, Pfizer’s former chief scientific officer, is embarking on a journey of curiosity and interconnectedness in his post-Big Pharma career.
Why Different Prescription Drugs Require Targeted Advertising
Drug Topics
APRIL 1, 2025
Jenny Markell, BA, joined us to discuss the nuances of drug promotion in the US and how specific medications are targeted to various patient populations.
How long does olanzapine take to work for anxiety?
The Checkup by Singlecare
APRIL 1, 2025
Olanzapine (brand names Zyprexa or Zyprexa Zydis) is a second-generation antipsychotic medication that’s FDA approved to treat mental health conditions like schizophrenia and bipolar disorder, including mixed or manic episodes. It’s also approved for treatment-resistant depression or depression with bipolar I disorder in combination with fluoxetine.
Q&A: Pharmacists Can Overcome Vaccine Hesitancy Through Trust and Communication | APhA 2025
Drug Topics
APRIL 1, 2025
In an era of persistent medical misinformation, addressing vaccine hesitancy has become a critical challenge for health care professionals.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
AI toolkit for pharmacy practice launched by FIP
Hospital Pharmacy Europe
APRIL 1, 2025
A new toolkit to support pharmacists when integrating artificial intelligence (AI) into daily practice has been launched by the International Pharmaceutical Federation (FIP). The toolkit for hospital, industry and community settings offers structured guidance on AI adoption. It covers ethical considerations, implementation strategies, regulatory compliance and real-world applications to help pharmacists optimise patient care, stimulate multidisciplinary interaction and enhance operational effici
As the Measles Outbreak Continues to Spread, Texas Hospitals Report Cases of Vitamin A Toxicity
Pharmacy Times
APRIL 1, 2025
The CDC reports 483 total cases across 20 states as of March 28, 2025.
Victor Alves Presenting at ASCA 2025 Conference & Expo in Denver
OctariusRx
APRIL 1, 2025
OctariusRx President and Consultant Pharmacist Victor Alves is presenting Pharmacy Documentation: Tips for Patient Safety and Survey Success at the ASCA 2025 Conference & Expo, April 30May 3, in Denver Colorado. He will discuss the essential elements of patient safety through complete pharmacy documentation. Additionally, he will address the most common survey issues and provide practical tips for improving patient safety and survey success.
Potential impact of Pharma Tariffs on Marketing
Pharma Marketing Network
APRIL 1, 2025
Introduction How might your pharmaceutical marketing strategy change if your core products suddenly became more expensive to import or export? Pharma tariffs have quickly emerged as a critical consideration for pharma marketing executives, reshaping how brands strategize, position, and market their products globally. As the landscape evolves, marketers need clarity on navigating this complex terrain effectively.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Study: Vitamin B12 Levels Within "Normal" Range Linked to Cognitive Decline in Older Adults
Pharmacy Times
APRIL 1, 2025
Current recommended levels of vitamin B12 might not be sufficient to protect against neurological decline.
RIF job losses are underway at HHS agencies; reports
pharmaphorum
APRIL 1, 2025
Reduction in force (RIF) job losses have started in earnest at US federal agencies, including the FDA and CDC, according to media reports
Intravenous Immunoglobulin Plus Rituximab Effective Alternative Option for Refractory Autoimmune Disease Treatment
Pharmacy Times
APRIL 1, 2025
Given rituximabs tendency to cause infections in patients being treated for autoimmune diseases, the addition of intravenous immunoglobulin works to reduce that risk and induce clinical improvements.
EVERSANA joins with Veeva in push to 'pharmatise AI'
pharmaphorum
APRIL 1, 2025
EVERSANA has joined the growing roster of companies partnering with Veeva on the development of GenAI applications for the life sciences industry
Spread Pricing & Dispensing Fees: Potential Legislation Tackles PBM Practices
Pharmacy Times
APRIL 1, 2025
The Protecting Pharmacies in Medicaid Act aims to tackle spread pricing, but other legislation could target different issues.
UK first to approve Rotop's prostate cancer imaging agent
pharmaphorum
APRIL 1, 2025
The UK has given a world-first approval to Rotop's RoTecPSMA, a new imaging agent for detecting lesions in men with prostate cancer
Everything You Need to Know From the American College of Cardiology 2025 Scientific Session
Pharmacy Times
APRIL 1, 2025
Host Craig Beavers spoke with several presenters, researchers, and experts about the key data being discussed at the meeting.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 1, 2025
The American Telemedicine Associations lobbying arm, ATA Action, acquired the Digital Therapeutics Alliance in a bid to beef up its digital health presence and advocate for health techno | The associations will join forces to advocate for health tech policy at the state, federal and international levels.
Finerenone Shows Promise in Heart Failure and Kidney Disease Management
Pharmacy Times
APRIL 1, 2025
John Ostrominski, MD shares insights into the safety and efficacy of finerenone, based on data from the FINEARTS-HF trial.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 1, 2025
SonderMind, a hybrid mental health provider, has expanded its virtual services to all 50 states. | The announcement comes on the heels of a rapid year of expansion for the company. Since the start of 2024, SonderMind has expanded to 35 new states.
ACC25: AZ stakes its claim to the oral PCSK9 category
pharmaphorum
APRIL 1, 2025
AstraZeneca has revealed phase 2b results with its oral PCSK9 inhibitor AZD0780 as it tries to narrow a lead held by MSD with its rival cholesterol drug
NCCN 2025: Advancing Breast Cancer Risk Assessment and Prevention Strategies
Pharmacy Times
APRIL 1, 2025
Evolving breast cancer risk models and prevention methods are necessary to improve patient outcomes, according to Sagar Sardesai, MD.
Large pharma drug licensing from China hits high at 28% in 2024
Pharmaceutical Technology
APRIL 1, 2025
Total deal value of innovator drug licensing agreements involving Chinese biopharma licensors has risen 66% to $41.5 billion in 2024.
Making M3P Work for Your Pharmacy: A Guide to Streamlining Enrollment and Supporting Patients
Pharmacy Times
APRIL 1, 2025
M3P will be a financial lifeline for seniors while lowering certain pharmacy costs, but more education and tools are needed to make it successful with pharmacies and their customers.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 1, 2025
Venteur, a startup that administers individual coverage health reimbursement arrangements, or ICHRA, has banked a $20 million funding round to continue building its reach.
Let's personalize your content